| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Marta Bosia, Cristina Lorenzi, Adele Pirovano, Carmelo Guglielmino, Federica Cocchi, Marco Spangaro, Placido Bramanti, Enrico Smeraldi, Roberto Cavallar. COMT Val158Met and 5-HT1A-R -1019 C/G polymorphisms: effects on the negative symptom response to clozapine. Pharmacogenomics. vol 16. issue 1. 2015-09-16. PMID:25560469. |
clozapine is still considered the gold standard for treatment-resistant schizophrenia patients; however, up to 40% of patients do not respond adequately. |
2015-09-16 |
2023-08-13 |
Not clear |
| Adam Wysokińsk. Fasting serum levels of neuropeptide y in patients with schizophrenia on clozapine monotherapy. Clinical neuropharmacology. vol 38. issue 1. 2015-09-04. PMID:25580919. |
fasting serum levels of neuropeptide y in patients with schizophrenia on clozapine monotherapy. |
2015-09-04 |
2023-08-13 |
human |
| Adam Wysokińsk. Fasting serum levels of neuropeptide y in patients with schizophrenia on clozapine monotherapy. Clinical neuropharmacology. vol 38. issue 1. 2015-09-04. PMID:25580919. |
we checked whether npy level in subjects with schizophrenia on clozapine is higher compared with healthy controls. |
2015-09-04 |
2023-08-13 |
human |
| O Schjerning, S Lykkegaard, P Damkier, J Nielse. Possible drug-drug interaction between pregabalin and clozapine in patients with schizophrenia: clinical perspectives. Pharmacopsychiatry. vol 48. issue 1. 2015-09-01. PMID:25295553. |
possible drug-drug interaction between pregabalin and clozapine in patients with schizophrenia: clinical perspectives. |
2015-09-01 |
2023-08-13 |
Not clear |
| F A Mustafa, J G Burke, S S Abukmeil, J J Scanlon, M Co. "Schizophrenia past clozapine": reasons for clozapine discontinuation, mortality, and alternative antipsychotic prescribing. Pharmacopsychiatry. vol 48. issue 1. 2015-09-01. PMID:25376977. |
"schizophrenia past clozapine": reasons for clozapine discontinuation, mortality, and alternative antipsychotic prescribing. |
2015-09-01 |
2023-08-13 |
Not clear |
| F A Mustafa, J G Burke, S S Abukmeil, J J Scanlon, M Co. "Schizophrenia past clozapine": reasons for clozapine discontinuation, mortality, and alternative antipsychotic prescribing. Pharmacopsychiatry. vol 48. issue 1. 2015-09-01. PMID:25376977. |
the clinical records of 190 patients with schizophrenia who discontinued clozapine between 1990 and 2012 in the county of northamptonshire were examined, in an attempt to answer the following questions. |
2015-09-01 |
2023-08-13 |
Not clear |
| Winnie Ng, Rossoune Kennar, Jack Uetrech. Effect of clozapine and olanzapine on neutrophil kinetics: implications for drug-induced agranulocytosis. Chemical research in toxicology. vol 27. issue 7. 2015-08-31. PMID:24968069. |
clozapine is effective in the treatment of schizophrenia; however, its use is limited by a relatively high incidence of idiosyncratic agranulocytosis. |
2015-08-31 |
2023-08-13 |
rat |
| Tarek K Rajji, Benoit H Mulsant, Simon Davies, Sawsan M Kalache, Christopher Tsoutsoulas, Bruce G Pollock, Gary Remingto. Prediction of working memory performance in schizophrenia by plasma ratio of clozapine to N-desmethylclozapine. The American journal of psychiatry. vol 172. issue 6. 2015-08-24. PMID:25859763. |
prediction of working memory performance in schizophrenia by plasma ratio of clozapine to n-desmethylclozapine. |
2015-08-24 |
2023-08-13 |
Not clear |
| Tarek K Rajji, Benoit H Mulsant, Simon Davies, Sawsan M Kalache, Christopher Tsoutsoulas, Bruce G Pollock, Gary Remingto. Prediction of working memory performance in schizophrenia by plasma ratio of clozapine to N-desmethylclozapine. The American journal of psychiatry. vol 172. issue 6. 2015-08-24. PMID:25859763. |
clozapine's potent antagonism of muscarinic m1 receptors is thought to worsen working memory deficits associated with schizophrenia. |
2015-08-24 |
2023-08-13 |
Not clear |
| Tarek K Rajji, Benoit H Mulsant, Simon Davies, Sawsan M Kalache, Christopher Tsoutsoulas, Bruce G Pollock, Gary Remingto. Prediction of working memory performance in schizophrenia by plasma ratio of clozapine to N-desmethylclozapine. The American journal of psychiatry. vol 172. issue 6. 2015-08-24. PMID:25859763. |
the authors hypothesized that the ratio of serum clozapine and ndmc concentrations would be inversely associated with working memory performance in schizophrenia. |
2015-08-24 |
2023-08-13 |
Not clear |
| Ruth Murphy, Anne Gallagher, Kapil Sharma, Tariq Ali, Elizabeth Lewis, Ivan Murray, Brian Hallaha. Clozapine-induced stuttering: an estimate of prevalence in the west of Ireland. Therapeutic advances in psychopharmacology. vol 5. issue 4. 2015-08-24. PMID:26301079. |
clozapine is the most effective treatment available for treatment-resistant schizophrenia; however, it is also associated with a large array of adverse effects that limits its tolerability. |
2015-08-24 |
2023-08-13 |
Not clear |
| J-M Batail, B Langrée, G Robert, S Bleher, M-C Verdier, E Bellissant, B Millet, D Drapie. Use of very-high-dose olanzapine in treatment-resistant schizophrenia. Schizophrenia research. vol 159. issue 2-3. 2015-08-19. PMID:25278103. |
in the literature, treatment with high-dose olanzapine (>20mg/day) appears to be a good alternative to clozapine, the gold standard for treatment-resistant schizophrenia. |
2015-08-19 |
2023-08-13 |
Not clear |
| Adam Wysokińsk. Blood levels of glucose and insulin and insulin resistance in patients with schizophrenia on clozapine monotherapy. Diabetes & metabolic syndrome. vol 8. issue 4. 2015-08-17. PMID:25311817. |
blood levels of glucose and insulin and insulin resistance in patients with schizophrenia on clozapine monotherapy. |
2015-08-17 |
2023-08-13 |
human |
| Pasquale De Fazio, Raffaele Gaetano, Mariarita Caroleo, Gregorio Cerminara, Francesca Maida, Antonio Bruno, Maria Rosaria Muscatello, Maria Jose Jaén Moreno, Emilio Russo, Cristina Segura-Garcí. Rare and very rare adverse effects of clozapine. Neuropsychiatric disease and treatment. vol 11. 2015-08-14. PMID:26273202. |
clozapine (clz) is the drug of choice for the treatment of resistant schizophrenia; however, its suitable use is limited by the complex adverse effects' profile. |
2015-08-14 |
2023-08-13 |
Not clear |
| Li Hui, Minjie Ye, Wei Tang, Feixue Zhang, Jiahong Liu, Linjing Liu, Yuanling Chen, Da-Chun Chen, Yun-Long Tan, Fu-De Yang, Xiang Yang Zhan. Obesity correlates with fewer symptoms in schizophrenia treated with long-term clozapine: gender difference. Psychiatry research. vol 225. issue 3. 2015-08-11. PMID:25595339. |
obesity correlates with fewer symptoms in schizophrenia treated with long-term clozapine: gender difference. |
2015-08-11 |
2023-08-13 |
Not clear |
| Dawn Bruijnzeel, Uma Suryadevara, Rajiv Tando. Antipsychotic treatment of schizophrenia: an update. Asian journal of psychiatry. vol 11. 2015-08-10. PMID:25216917. |
whereas clozapine is found to be more efficacious than other agents among otherwise treatment-refractory schizophrenia patients, other differences in efficacy between antipsychotic agents are minor. |
2015-08-10 |
2023-08-13 |
Not clear |
| Adam Wysokiński, Marek L Kowalski, Iwona Kłoszewsk. Serum levels of desacyl ghrelin in patients with schizophrenia on clozapine monotherapy. Psychiatry and clinical neurosciences. vol 68. issue 12. 2015-08-03. PMID:24773632. |
serum levels of desacyl ghrelin in patients with schizophrenia on clozapine monotherapy. |
2015-08-03 |
2023-08-13 |
Not clear |
| Lin Yang, Jianhua Chen, Dengtang Liu, Shunying Yu, Enzhao Cong, Yan Li, Haisu Wu, Ying Yue, Sai Zuo, Yan Wang, Shiqiao Liang, Yongyong Shi, Shenxun Shi, Yifeng X. Association between SREBF2 gene polymorphisms and metabolic syndrome in clozapine-treated patients with schizophrenia. Progress in neuro-psychopharmacology & biological psychiatry. vol 56. 2015-07-31. PMID:25201120. |
patients with schizophrenia using antipsychotics often develop metabolic side effects, especially with clozapine. |
2015-07-31 |
2023-08-13 |
Not clear |
| Young Sup Woo, Hee-Ryung Wang, Bo-Hyun Yoon, Sang-Yeol Lee, Kwang Hun Lee, Jeong Seok Seo, Won-Myong Bah. Bioequivalence of Generic and Brand Name Clozapine in Korean Schizophrenic Patients: A Randomized, Two-Period, Crossover Study. Psychiatry investigation. vol 12. issue 3. 2015-07-24. PMID:26207129. |
clozapine is the treatment of choice for refractory schizophrenia. |
2015-07-24 |
2023-08-13 |
Not clear |
| Souhail Bannour, Saoussen Bouhlel, Mohamed Wassim Krir, Badii Amamou, Selma Ben Nasr, Yousri El Kissi, Bechir Ben Hadj Al. Combination of maintenance electroconvulsive therapy and clozapine in treating a patient with refractory schizophrenia. The journal of ECT. vol 30. issue 3. 2015-07-20. PMID:24820944. |
combination of maintenance electroconvulsive therapy and clozapine in treating a patient with refractory schizophrenia. |
2015-07-20 |
2023-08-13 |
Not clear |